Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    12.00 (1.88%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Trading Statement

18 Dec 2007 14:46

Avingtrans PLC18 December 2007 AVINGTRANS plc Trading Update Following the conclusion of the first half ended 30 November 2007 it is nowclear that the Board's earlier optimism for the full year to 31 May 2008 hasfaltered. The state of the Group's orderbook earlier in the year underpinned theBoard's confidence that the Group's overall result for the year would besufficient to offset the disappointing performance within the aerospace divisionwhich we have previously reported. The current state of the orderbook no longerprovides such underpinning. As a result the Directors expect that, whilstprofitable at the pre-tax level on a Group-wide basis, the Group's overallperformance for the full year to 31 May 2008 will fall significantly short ofour expectations. With the help of an encouraging performance in the industrial division duringthe first half of the financial year the Directors also expect to report apre-tax profit at the interim stage, albeit at a level which also falls short ofour previous expectation. On a more encouraging note, the Directors areoptimistic of an improved half on half performance during the remainder of thecurrent financial year on the back of a number of interesting opportunitieswhich are currently under consideration. The Directors expect to announce thefirst half results in February 2008. The problems within the aerospace division have already been highlighted to themarket. These relate to contractual terms on certain important supply contractsat B&D yielding negative margins during the first half of the year on a materialpart of the division's business. In recent weeks prices have been renegotiatedwith the customer concerned. Whilst material improvements on future deliverieshave been achieved, no retrospective support has been agreed to. As a result theaerospace division was loss making in the first half of the year. This contractwill end during the current financial year. Board changes After 5 years with the Group Steven Lawrence, Managing Director has decided toleave the company by the end of May 2008. The Board is actively seeking areplacement and has identified a potential candidate. Once negotiations arecompleted a further announcement will be made. Enquiries: Avingtrans plc 01159 499 020Ken Baker, ChairmanStephen King, Finance Director KBC Peel Hunt Ltd (Nominated Adviser & Broker) 020 7418 8900Julian Blunt or David Anderson This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.